GSA Capital Partners’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$362K Sell
169,767
-75,954
-31% -$181K 0.02% 1129
2025
Q4
$597K Buy
245,721
+122,963
+100% +$435K 0.05% 693
2025
Q3
$465K Sell
122,758
-117,253
-49% -$343K 0.04% 893
2025
Q2
$595K Buy
+240,011
New +$463K 0.04% 800
2024
Q3
Sell
-16,814
Closed -$78K 1600
2024
Q2
$78K Buy
+16,814
New +$90.3K 0.01% 1545
2022
Q4
Sell
-22,486
Closed -$38K 1470
2022
Q3
$38K Buy
+22,486
New +$69.3K 0.01% 1436
2021
Q4
Sell
-69,299
Closed -$586K 1412
2021
Q3
$586K Sell
69,299
-3,547
-5% -$35K 0.06% 605
2021
Q2
$888K Buy
72,846
+51,646
+244% +$1.02M 0.1% 307
2021
Q1
$514K Buy
+21,200
New +$572K 0.09% 338

Other funds holding BDTX